Genovate Biotechnology Co., Ltd. (TPEX:4130)
Taiwan · Delayed Price · Currency is TWD 32.00
-0.60 (-1.84%)
Feb 11, 2026, 1:30 PM CST
Genovate Biotechnology Market Cap
Genovate Biotechnology has a market cap or net worth of 3.71 billion as of February 11, 2026. Its market cap has increased by 33.54% in one year.
Market Cap
3.71B
Enterprise Value
3.24B
Revenue
491.23M
Ranking
n/a
PE Ratio
339.40
Stock Price
32.00
Market Cap Chart
Since November 3, 2008, Genovate Biotechnology's market cap has increased from 664.80M to 3.71B, an increase of 457.80%. That is a compound annual growth rate of 10.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 3.71B | 17.69% |
| Dec 31, 2025 | 3.15B | 35.56% |
| Dec 31, 2024 | 2.32B | -20.11% |
| Dec 29, 2023 | 2.91B | -17.02% |
| Dec 30, 2022 | 3.51B | 31.05% |
| Dec 30, 2021 | 2.68B | -15.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ACRO Biomedical | 4.25B |
| Formosa Pharmaceuticals | 4.15B |
| Energenesis Biomedical CO.,LTD. | 4.12B |
| BRIM Biotechnology | 3.90B |
| Intech Biopharm | 3.82B |
| Syngen Biotech | 3.54B |
| Shine-On BioMedical | 3.47B |
| 3D Global Biotech | 3.30B |